Chromatographic determination of sulfasalazine and its active metabolites : greenness assessment and application to spiked human plasma

© 2020 John Wiley & Sons, Ltd..

Green TLC-densitometric and RP-HPLC methods were developed and validated for the determination of the active prodrug sulfasalazine (SZ), its active metabolite mesalazine (MZ) and the major active metabolite of mesalazine, N-acetyl-5-aminosalicylic acid (AS). In the developed TLC-densitometric method, chromatographic separation was carried out on TLC silica gel plates 60 F254 using a developing system consisting of ethyl acetate-methanol-ammonia solution 33% (8:2.5:0.3, by volume) and then scanning the separated bands at 215 nm using hydrochlorothiazide as an internal standard with linearity ranges of 0.4-3, 0.4-2.4 and 0.3-2 for SZ, MZ and AS, respectively. The developed RP-HPLC method depended on chromatographic separation using a C18 column with a solvent mixture of methanol-aqueous acetic acid solution (pH 5) as a mobile phase with gradient elution mode and UV scanning at 243 nm using pyrazinamide as internal standard with linearity ranges of 5-50, 5-40, and 3-20 for SZ, MZ and AS, respectively. US Food and Drug Administration guidelines were followed during validation of the methods. The greenness of the developed methods was estimated using the greenness profile and the Eco-Scale approach. Both methods passed the four quadrants of the greenness profile and had Eco-Scale score ˃75, thus they were considered to be green according to these approaches.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:34

Enthalten in:

Biomedical chromatography : BMC - 34(2020), 4 vom: 01. Apr., Seite e4804

Sprache:

Englisch

Beteiligte Personen:

Abdelrahman, Maha M [VerfasserIn]
Habib, Neven M [VerfasserIn]
Emam, Aml A [VerfasserIn]
Mahmoud, Hamada M [VerfasserIn]
Abdelwhab, Nada S [VerfasserIn]

Links:

Volltext

Themen:

3XC8GUZ6CB
Journal Article
Mesalazine
N-acetyl-5-aminosalicylic acid
RP-HPLC
Sulfasalazine
TLC

Anmerkungen:

Date Completed 20.04.2020

Date Revised 20.04.2020

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1002/bmc.4804

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM306079003